In the United States, the COVID-19 vaccine of Moderna has been approved for adults on Monday. The CEO of Moderna, Stephane Bancel, had a conversation with the US Food and Drug Administration (FDA) to carry a “momentous milestone” for the organization.
On Monday, the US Food and Drug Administration (FDA) has declared permission to the Moderna’s COVID-19 vaccine “Spikevax”. Moreover, the Spikevax was also used in the United States during the time of the pandemic.
The acting FDA commissioner Janet Woodcock mentioned in a statement, “The population can be guaranteed that the COVID-19 vaccination fulfils the standards of the FDA for protection, efficiency as well as the quality of the manufacturing required for the vaccine approved to be used in the United States.”
Woodcock further said, “The acceptance of the vaccine by the FDA is a considerable effort that has been made to defeat the COVID-19 variant, highlighting the second vaccine approved assented to stop COVID-19.”
However, the Moderna vaccine has been approved for people of 18-year-old or more.
At the end of August month, the Pfizer vaccine was taken into account for people ages 16 or older by the US Food and Drug Administration (FDA).
Bancel mentioned in a statement, “The COVID-19 vaccine has helped all the people around the globe, millions of individuals were safe and protected from the COVID-19 infection, hospitalization as well as facing deaths.”
As per the information provided by the FDA, the most familiar side effects of the vaccine that has been noticed include pain at the area where the injection is inserted, fatigue, muscle, headaches and more.
